
Showing 41 - 60 of 108 results
It's GO time
nandin member, SVSR, report on their proof-of-concept for a reusable Graphene Oxide (GO) membrane to capture waste water vapours from ageing sewerage systems.
Emerging from the deep: Stawell’s dark matter lab takes shape

ANSTO Synroc® - Radioactive Waste Treatment Technology
ANSTO Synroc technology provides a safe, secure matrix for the immobilisation and final disposal of radioactive waste.

User Meeting 2020 Invited Speakers
The User Advisory Committee (UAC) are pleased to present this year's invited speakers.
Hungarian Ambassador attends ceremony to mark installation of new imaging scanners
The Hungarian Ambassador to Australia and a small delegation visited ANSTO for a special ceremony to mark the installation and commissioning of two new nuclear medicine scanners from the Hungarian company Mediso Pacific.
Appointment of ANSTO Board Deputy Chairperson Andrew Carriline
Minister for Industry and Science, the Hon Ed Husic MP has formally announced the appointment of Mr Andrew Carriline as ANSTO Board Deputy Chairperson, effective from Thursday 9 May 2024.
ANSTO and University of Wollongong collaborate on new quality control device to enhance precision in advanced cancer treatment
Researchers from the Health Research and Technology Group at ANSTO and the University of Wollongong have developed a new device that could improve the quality control of accelerator-based boron neutron capture therapy, a promising radiation therapy for treating aggressive cancers.

Role at ANSTO
Leena works on the development of new ligand systems for 68Ga and 177Lu.

United Uranium Scholarship - Guidelines
This scholarship recognises outstanding ability and promise in the field of nuclear science and technology, specifically as it applies to nuclear energy. Successful applicants will demonstrate a history of interest in nuclear energy and a desire to continue this interest.

Role at ANSTO
Supply of nuclear medicine in the news
Lutetium-177 used for advanced prostate cancer
Progress on advanced prostate cancer
Updated results show radiation therapy using lutetium-177 improved survival in advanced prostate cancer.
New Medicines Manufacturing Innovation Centre, co-located at the Australian Synchrotron, opened
The newly built Medicines Manufacturing Innovation Centre (MMIC), co-located at the Australian Synchrotron at Clayton, was officially opened on Wednesday by the Victorian Deputy Premier and Minister for Medical Research the Hon Ben Carroll.
Students tackle a real-world challenge regarding dissimilar-metal corrosion in a project supported by BlueScope
Constructing the world's newest nuclear medicine manufacturing facility
Principal Technical Consultant Michael Druce shares some personal insights on the design and construction of ANSTO's nuclear medicine facility.
Meteorites from the red desert of Australia support search for life on the red planet Mars
Monash University, University of Queensland and Australian National University researchers have used ANSTO’s Australian Synchrotron in their study of meteorites found on Earth that could be used in future to find evidence of life on the planet Mars.
Tracing the impact of toxic metals
Two ANSTO environmental scientists are part of a large team led by the Australian National University (ANU), who have received an Australian Research Council Discovery Project grant to investigate how environmental change and human activities since industrialisation have impacted the transport and deposition of toxic metals on the south coast of Australia, Tasmania, and remote Southern Ocean islands.
More progress understanding how COVID-19 invades the body
Using the Australian Synchrotron, an international team of researchers has characterised an important interaction that helps the SARS-CoV-2 virus invade human cells.

Mr Andrew Carriline is an experienced senior business executive, commercially astute and highly skilled at operating successfully in regulated environments.